Initiation of the IIMPACT study follows promising Phase 1 results where Restem-L demonstrated clinically meaningful efficacy and a significant ...

Patients reveal persistent gaps in genetic testing, diagnosis, and clinical trial access—and implications for advancing ...

Learn about surgical options for hypertrophic cardiomyopathy (HCM), including septal myectomy, septal ablation, and heart ...

Participants will each receive a single intravenous infusion of AFTX-201 at doses determined from preclinical studies.

Researchers at Johns Hopkins University School of Medicine have identified a subgroup of patients with necrotizing myopathy who have a novel autoantibody specificity that makes them potential ...

HCM is a genetic disease, usually caused by mutations in sarcomere proteins such as myosin, actin, tropomyosin, and myosin-binding protein C.

The number of patients diagnosed with cardiomyopathy has increased substantially over the past two decades. This is the ...

An 81-year-old man presented to our emergency department with a 3-day history of fever and cough and was given a diagnosis of pneumonia. He reported a 9-kg weight loss over 2 years. He also reported ...

Please provide your email address to receive an email when new articles are posted on . Black patients with hypertrophic cardiomyopathy were often diagnosed at a younger age and were less likely to ...

Statins are prescribed to millions of people worldwide to reduce their risks of suffering heart attacks and strokes. Researchers at the University of Oxford, in collaboration with other researchers, ...